Athersys, Inc.

http://www.athersys.com/
Tags:HealthPharmacyPlatformProduct
Athersys, Inc. is a biopharmaceutical company applying its proprietary stem cell platform MultiStem® to develop products in the areas of regenerative medicine, cardiovascular, neurological, inflammatory and immune diseases. MultiStem® is currently being evaluated in several preclinical and clinical stage programs. Athersys, Inc. shares are publicly traded on NASDAQ (NASDAQ:ATHX).
Location: United States, Cleveland

Investors 2

Mentions in press and media 13

DateTitleDescriptionCategoryAuthorSource
12.10.2018Meeting’...This was a far cry from the fi...--medcitynew...
28.04.2014First effi...Cleveland-based Athersys (NASD...--medcitynew...
14.08.2013Stem cell ...Already the company has two Ph...--medcitynew...
10.02.2010Athersys g...Athersys said Wednesday it has...--medcitynew...
14.01.2010Biopharmac...If Athersys did sell shares or...--medcitynew...
04.01.2010University...A new and improved Hillcrest H...--medcitynew...
23.12.2009Athersys t...On Monday, the Pfizer unit str...--medcitynew...
22.12.2009New tax on...Nationwide Children’s H...--medcitynew...
21.12.2009Athersys I...“We think that having Pfizer...--medcitynew...
08.12.2009Cleveland ...Promoted Telemedicine’s pot...--medcitynew...
Show more